Fig. 1 · Structure
Documents & Downloads
Sontigidomide
Antineoplastic Compound
Sontigidomide is an antineoplastic compound that exhibits cytotoxic effects by significantly inhibiting MOLM-13 cell proliferation. At a concentration of 1 μM over a period of three days, Sontigidomide reduces cell viability by more than 80%. This compound is relevant for research applications focusing on cancer biology and the development of targeted therapies for hematologic malignancies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2560577-69-5 |
| Applications | Antineoplastic Compound |
| Formula | C26H22F3N3O5 |
| Molecular Weight | 513.47 |
| SMILES | O=C(C(C1=CC=C(C2(C(F)(F)F)CC2)C=C1)=O)NCC3=CC=C4C(N(C5C(NC(CC5)=O)=O)CC4=C3)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.